The discontinuation of Lemon Skunk and the introduction of Jack Haze by Spectrum Therapeutics are significant events in the medical cannabis market that shed light on...
Vitesse Arnhem, facing financial crisis and forced relegation from Eredivisie due to point deduction, launches a crowdfunding campaign. Ex-players and fans, including rivals NEC Nijmegen, donate...
Iwoca secures a 175 million euro credit line exclusively for the German market from US bank Citi and asset manager Insight Investment. Iwoca aims to strengthen...
Zolgensma, Novartis' gene therapy for SMA, remains the world's most expensive medicine, priced between $1.2 million and $2.1 million per dose. Despite its high cost, it's...
FTX unveils a new reorganization plan, offering hope for creditors after its dramatic collapse. Under the plan, billions could flow to creditors, with 98% expected to...
European stock markets tread cautiously amidst mixed signals: positive corporate profits clash with uncertainty over central banks' next moves. ECB member Pierre Wunsch's speech looms for...
The pharmaceutical industry sees a surge in R&D investment, reaching $145.5 billion last year, 4.5% higher than drug launch budgets in 2022. Deloitte's report on pharmaceutical...
Bitcoin's rally hits a roadblock, dropping to $57,000 from its peak of $73,000 in March. USA Bitcoin ETF investments pause, causing market unease. Glassnode's analysis suggests...
J4ENERGY, specializing in energy transition through AI, completes its initial capital raise surpassing €1 million. Supported by RoboIT, Tech4Planet, and Pariter Robotics, it offers the "Energy...
The sale of the High Times assets is a significant event for the cannabis industry, highlighting both market volatility and the effects of financial management in...